Royal Society of Chemistry 日英セミナー
<RSC日英セミナー>
Open seminar:‘Challenges facing drug discovery in Japan and the UK-how can
these challenges be met?’
2013年1月29日(火)
於 化学会館7 階ホール
OBJECTIVE(S):
・To provide an overview to a range of stakeholders on the current drug discovery processes in japan and the UK.
・To create a forum for the open discussion of current challenges facing translational medicine and thoughts on how these should be addressed.
1400-1430 :Registration
1430-1435 :Opening remarks
1435-1455 :Introduction to the session – Dr Dayfdd Owen(Pfizer)
・Provide a very brief introduction on Target Validation
・Summarise key points from previous l.5 days workshop at the British Embassy
・Similarities/Differences between UK and Japan
1455-1500 :Q&A
1500-1520 :Prof Chas Bountra (University of Oxford)
【Drug discovery landscape in the UK】
1520-1540 :Dr Yoshinobu Hirayama (Ministry of Health, Labour and Welfare)
【Medical Innovation Policy and Regulatory Initiative in Japan】
1540-1545 :Q&A
1545-1600 :Coffee break
1600-1625 :Professor Toshio Tanaka (MieUniversity)
【Target Validation and Zebrafish-based Systems Pharmacology】
(ターゲットバリデーションとゼプラフィッシュによるシステムズ薬理学)
1625-1650 :Prof Andrew Hopkins(University of Dundee)
【Adaptive Drug Discovery】
1650-1715 :Professor Toshio Miyata(Tohoku University)
【Drug Discovery and Development from Academia】
(アカデミア発創薬・臨床開発)
1715-1740 :Professor Praveen Anand (Imperial College of London)
【Target Validation for Novel Analgesics: Paradigm for Clinical Translation】
1740-1745 :Closing remarks
1745-1900 :Networking reception